Rivulet Media Inc (fka RIVU)

[Inoviorulez]

Yes that's because there are many reasons why orphan drug companies are wanted more by investors. LIke SRPT, VRTX, BMRN etc.

1. Easy way with the FDA. When your drug is orphan drug status not only do you get approved faster, you are less likely to be refused by the FDA when it comes time for a vote for approvl.

2. Second you have a drug that treats a rare disease with no other approved therapies. Therefore why the companies charge so much. Cystic fibrosis drug from Vertex charges $295,000 per year per patient.

3. The third point comes back to the 2nd point no competition. Meaning all profit made only goes to the orphan drug company.

What's good about BMSN when they get the go ahead to start phase 1 is they want to file for Orphan drug status. That should be another catalyst for the stock.